Comment in

• Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance.

  Sanna G, Bertolaccini ML, Mameli A, Hughes GR, Khamashta MA, Mathieu A. Sanna G, et al. Ann Rheum Dis. 2005 Dec;64(12):1795-6. doi: 10.1136/ard.2005.038430. Ann Rheum Dis. 2005. PMID: 16284349 Free PMC article. No abstract available.
• Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation.

  Provitera V, Nolano M, Pappone N, Lubrano E, Stancanelli A, Lanzillo B, Santoro L. Provitera V, et al. Rheumatology (Oxford). 2007 Nov;46(11):1739-41. doi: 10.1093/rheumatology/kem251. Epub 2007 Oct 15. Rheumatology (Oxford). 2007. PMID: 17938133 No abstract available.
• Antibody response to pneumococcal polysaccharide vaccine in systemic sclerosis.

  Mercado U, Acosta H, Diaz-Molina R. Mercado U, et al. J Rheumatol. 2009 Jul;36(7):1549-50. doi: 10.3899/jrheum.081227. J Rheumatol. 2009. PMID: 19567636 Clinical Trial. No abstract available.